FDA Drug Application (202231) for LEVOTHYROXINE SODIUM by FRESENIUS KABI USA

Back to FDA Applications sponsored by FRESENIUS KABI USA

Application Number202231
Product Number001
FormPOWDER;INTRAVENOUS
Dosage100MCG/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameLEVOTHYROXINE SODIUM
Active IngredientLEVOTHYROXINE SODIUM



Back to FDA Applications sponsored by FRESENIUS KABI USA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.